Literature DB >> 20103031

Angiotensin-converting enzyme-related cough among Chinese-Americans.

Daniel S Tseng1, Jan Kwong, Firozeh Rezvani, Ashley O Coates.   

Abstract

BACKGROUND: Few studies have examined the relationship between ethnicity and tolerance of hypertension medications. We investigated the perception that Chinese-Americans may have a higher incidence of chronic cough from angiotensin-converting enzyme inhibitors.
METHODS: We searched electronic databases to identify patients who had received a new lisinopril prescription. This cohort was separated into 295 patients of Chinese descent and 4263 patients in the general population group with an instrument that used surnames to identify Chinese ethnicity. For those who discontinued lisinopril within 1 year, we reviewed medical records to determine reasons for discontinuation. We compared rates of discontinuation overall and due to cough by ethnic group (Chinese vs general population).
RESULTS: The Chinese population was more likely to discontinue their medication (47%) than the general population (31%). When the cause for discontinuation was examined, cough was significantly higher among Chinese, with a relative risk of 2.53; 95% confidence interval (CI), 2.11-3.03. The risk for angioedema was <1%, and no difference in the risk of angioedema was found between the 2 groups. When controlled for age, sex, and smoking, the risk of cough among Chinese-Americans remained significant (relative risk 2.63; 95% CI, 2.20-3.15).
CONCLUSIONS: We observed that our Chinese group was more than twice as likely as the general population to discontinue lisinopril due to cough, controlling for the influence of sex, age, and smoking. Copyright (c) 2010 Elsevier Inc. All rights reserved.

Entities:  

Mesh:

Substances:

Year:  2010        PMID: 20103031     DOI: 10.1016/j.amjmed.2009.06.032

Source DB:  PubMed          Journal:  Am J Med        ISSN: 0002-9343            Impact factor:   4.965


  10 in total

1.  Pollen count and presentation of angiotensin-converting enzyme inhibitor-associated angioedema.

Authors:  Brittany Straka; Hui Nian; Chantel Sloan; James Brian Byrd; Alencia Woodard-Grice; Chang Yu; Elizabeth Stone; Gary Steven; Tina Hartert; Koon K Teo; Guillaume Pare; Catherine A McCarty; Nancy J Brown
Journal:  J Allergy Clin Immunol Pract       Date:  2013-06-21

2.  Incidence of discontinuation of angiotensin-converting enzyme inhibitors due to cough, in a primary healthcare centre in Singapore.

Authors:  Lai Peng Ng; Paul Soo Chye Goh
Journal:  Singapore Med J       Date:  2014-03       Impact factor: 1.858

Review 3.  Target blood pressure in diabetes patients with hypertension--what is the accumulated evidence in 2011?

Authors:  Peter M Nilsson
Journal:  J Zhejiang Univ Sci B       Date:  2011-08       Impact factor: 3.066

4.  Incidence of angiotensin-converting enzyme inhibitor-induced cough in a Malaysian public primary care clinic: A retrospective cohort study.

Authors:  Hou Chan Loo; Fairuz Osman; Siew Lee Ho; Sing Yee An; Yim Mei Au Yong; Ee Ming Khoo
Journal:  Malays Fam Physician       Date:  2022-03-22

5.  Angiotensin converting enzyme inhibitors from medicinal plants: a molecular docking and dynamic simulation approach.

Authors:  Olumide Samuel Fadahunsi; Olubukola Sinbad Olorunnisola; Peter Ifeoluwa Adegbola; Temitayo I Subair; Oluwabamise Emmanuel Elegbeleye
Journal:  In Silico Pharmacol       Date:  2022-10-13

6.  Effect of valsartan on N-terminal pro-brain natriuretic Peptide in patient with stable chronic heart failure: comparison with enalapril.

Authors:  Young Soo Lee; Kee Sik Kim; Jin Bae Lee; Jae Kean Ryu; Ji Yong Choi; Byong-Kyu Kim; Sung Gug Chang; Seung Ho Hur; Bong Ryeol Lee; Byung Chun Jung; Geu Ru Hong; Byung Soo Kim; Tae Ho Park; Young Dae Kim; Tae Ik Kim; Dong Soo Kim
Journal:  Korean Circ J       Date:  2011-02-28       Impact factor: 3.243

7.  Zofenopril and incidence of cough: a review of published and unpublished data.

Authors:  Stefano Omboni; Claudio Borghi
Journal:  Ther Clin Risk Manag       Date:  2011-11-29       Impact factor: 2.423

8.  Angiotensin Receptor Blockers as an Alternative to Angiotensin-Converting Enzyme Inhibitors in Patients with Acute Myocardial Infarction Undergoing Percutaneous Coronary Intervention.

Authors:  Sungmin Lim; Eun Ho Choo; Ik Jun Choi; Sang Hyun Ihm; Hee Yeol Kim; Youngkeun Ahn; Kiyuk Chang; Myung Ho Jeong; Ki Bae Seung
Journal:  J Korean Med Sci       Date:  2019-11-25       Impact factor: 2.153

9.  The impact of angiotensin-converting-enzyme inhibitors versus angiotensin receptor blockers on 3-year clinical outcomes in patients with acute myocardial infarction without hypertension.

Authors:  Ae-Young Her; Byoung Geol Choi; Seung-Woon Rha; Yong Hoon Kim; Cheol Ung Choi; Myung Ho Jeong
Journal:  PLoS One       Date:  2020-11-30       Impact factor: 3.240

10.  SLCO1B1 Variants and Angiotensin Converting Enzyme Inhibitor (Enalapril)-Induced Cough: a Pharmacogenetic Study.

Authors:  Jian-Quan Luo; Fa-Zhong He; Zhen-Min Wang; Ning-Ling Sun; Lu-Yan Wang; Gen-Fu Tang; Mou-Ze Liu; Qing Li; Xiao-Ping Chen; Zhao-Qian Liu; Hong-Hao Zhou; Wei Zhang
Journal:  Sci Rep       Date:  2015-11-26       Impact factor: 4.379

  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.